On the other hand, liraglutide was found to be less effective for weight loss compared with the other 2 drugs, leading to a slow decline in use. Additionally, modifying dietary habits and lifestyle behaviors may be essential for optimizing weight loss outcomes. The Role of the EmployerIn an interview with AJMC, Dawn Weddle, vice president of the Midwest Business Group on Health (MBGH), was frank on her views of the semaglutide shortage. The session acknowledged the conundrum employers face in navigating the challenges of covering GLP-1 medications. The semaglutide shortage issue has gained significant mainstream attention throughout 2023, prompting Novo Nordisk to increase funding to enhance production capacity.

Source: CNN December 22, 2023 06:54 UTC